Search

Search results

8 results found

Partners

The consortium was a collaboration between the Carpenter-Singh Lab, the Genetic Perturbation Platform, and the Center for the Development of Therapeutics at the Broad Institute of MIT and Harvard along with industry and non-profit partners that were committed to creating a public Cell Painting...

Cell Painting

The Carpenter lab and Schreiber lab at the Broad Institute of MIT and Harvard developed Cell Painting, a microscopy assay that generates images that reflect cell response to treatments such as drug or genetic perturbations, in high-throughput (at a scale of 100,000+ perturbations). The Carpenter lab...

More info

Frequently Asked Questions (FAQ) Is it too late to join? Yes, the Consortium has finished its work optimizing, producing data, and publicly releasing it. There are two new Consortia to consider: OASIS (‘Omics for Assessing Signatures for Integrated Safety): Together with HESI, we aim to test Cell...

'Genetic Engineering & Biotechnology News' Features JUMP-Cell Painting

Genetic Engineering & Biotechnology News today featured Dr. Anne Carpenter and her group at the Broad Institute for their work launching a Cell Imaging Consortium. The consortium includes 12 pharmaceutical and biotechnology companies and received funding through the Massachusetts Life Sciences...

'Nature Reviews Drug Discovery' news article on Cell Painting

The JUMP-Cell Painting Consortium is alluded to in the Nature Reviews Drug Discovery news item, " Machine learning brings cell imaging promises into focus". The article overviews the entire field of image-based profiling and phenotype discovery, including industry and academic developments.